What Actually Happens After a Stem Cell Therapy Infusion
An intravenous cell infusion is undramatic to watch. The preparation is given slowly through a standard cannula while observations — pulse, blood pressure, temperature and oxygen saturation — are recorded at intervals, and a clinician remains present throughout.
Patients are usually observed for a period afterwards before leaving, precisely because the small number of reactions that do occur tend to declare themselves early. That observation window is part of the treatment, not an optional extra.
Expected Stem Cell Therapy Side Effects in the First 48 Hours
The commonly reported effects are mild: a low-grade temperature, tiredness, a headache, mild nausea, or soreness where the cannula sat. Where cells or a preparation have been injected into a joint or soft tissue, local ache and stiffness for a day or two is typical.
These generally settle without intervention. What matters clinically is the trajectory: symptoms that ease over hours are expected, symptoms that intensify are not.
Uncommon and Serious Risks of Stem Cell Therapy
Rare but recognised risks include allergic or infusion reactions, infection at an injection site, bleeding or bruising in patients on anticoagulation, and complications related to the procedure itself where cells are harvested surgically.
Risk also rises sharply with unproven routes of administration and with preparations of unknown provenance. Any consent conversation that does not name these possibilities is incomplete, whatever the marketing says.
How Screening Reduces Stem Cell Therapy Risk
Most avoidable harm is avoided before treatment day. A proper assessment reviews your diagnosis, medication list, clotting status, infection risk, cardiac and renal function, and recent imaging, and weighs all of it against the proposed therapy.
Active untreated malignancy, uncontrolled infection, pregnancy and unstable organ disease without specialist clearance are standard reasons to defer or decline. Our physicians follow the same review process described on the MSC therapy page.
What Cell Release Testing Rules Out
Before a batch is released for clinical use it should be tested for bacterial and fungal contamination, mycoplasma and endotoxin, with identity and viability confirmed. These tests exist to rule out the failure mode that causes the most serious harm: administering a contaminated preparation.
You are entitled to ask which of these were run on the material you will receive. Sourcing and processing differences are discussed in more depth in our comparison of UC-MSC and autologous cells.
Warning Signs in Unregulated Markets
The reliable red flags are consistent worldwide: guaranteed outcomes, treatment offered without examination or records, the same protocol for unrelated conditions, no named physician, no written consent, and no documentation of what was administered.
Pressure to decide quickly, or to pay before any medical review has taken place, belongs on the same list. A programme confident in its standards has no reason to rush you.
When to Contact Your Physician
Get medical advice promptly for a persistent high fever, breathlessness, chest pain, severe or spreading pain, redness or swelling at an injection site, or any symptom that is worsening rather than settling after the first day or two.
International patients should leave with written aftercare notes and a direct contact channel, so advice does not depend on time zones. You can reach our team through the contact page or on WhatsApp.
Ask Us the Difficult Questions First
Our medical team will walk through risks, screening and what is documented before you commit to anything. Learn more about MRC Healthcare or arrange a consultation.
Schedule a Consultation
